Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples